- Psychemedics Corporation Reports First Quarter 2024 Financial Results
- Psychemedics Corporation Reports 2023 Financial Results
- Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
- Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
- Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
- Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
- Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
More ▼
Key statistics
On Wednesday, Psychemedics Corp (PMD:NAQ) closed at 2.58, 25.24% above the 52 week low of 2.06 set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.63 |
---|---|
High | 2.67 |
Low | 2.58 |
Bid | 2.45 |
Offer | 3.00 |
Previous close | 2.62 |
Average volume | 4.26k |
---|---|
Shares outstanding | 5.81m |
Free float | 4.49m |
P/E (TTM) | -- |
Market cap | 15.20m USD |
EPS (TTM) | -0.773 USD |
Annual div (ADY) | -- |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 24 2023 |
Div pay-date | Jun 08 2023 |
Data delayed at least 15 minutes, as of May 22 2024 20:59 BST.
More ▼